This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Free CME: Commentary

The Differential Diagnosis and Treatment of Mild Cognitive Impairment and Alzheimer Disease

Allan Anderson, MD,a and Matthew Malone, DO, MBAa

Published: December 26, 2022

Abstract

Identifying patients at risk for developing mild cognitive impairment (MCI) and Alzheimer disease (AD) remains challenging in clinical practice, even as scientific understanding of dementia advances generally. That said, successfully navigating the associated differential diagnosis in AD is essential, as various causes of cognitive impairment require different treatment strategies. In recent years, the armamentarium in AD has expanded with regulatory approval of a disease-modifying therapy—aducanumab—and may be shifting away from symptomatic treatments such as cholinesterase inhibitors and memantine. Concurrently, the role of biomarkers in AD is increasing, and these entities may soon play a greater role in determining patient eligibility for prophylactic interventions and the likelihood of disease progression. As the standard of care progresses, clinicians should educate patients and their care providers on the implications of these advances and reinforce lifestyle changes that can delay or prevent the onset of disease in those at risk of AD. In doing so, care providers can deliver the best care possible.


PDF version of article
Note: To receive credit, you must navigate through the entire online activity. Click link below.

SEE THE ENTIRE ACTIVITY

J Clin Psychiatry 2023;84(1):BG21120COM4
To cite: Anderson A, Malone M. The differential diagnosis and treatment of mild cognitive impairment and Alzheimer disease. J Clin Psychiatry. 2023;84(1):BG21120COM4
a https://doi.org/10.4088/JCP.BG21120COM4
© Copyright 2022 Physicians Postgraduate Press, Inc.

aBanner Alzheimer’s Institute, Tucson, Arizona

Volume: 84

Quick Links: Dementia , Neurologic and Neurocognitive

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Clinical and Practical Psychopharmacology

Skeletal and Dental Fractures Associated With Electroconvulsive Therapy

Recent data suggest the risk of skeletal or dental fracture with ECT may be as low as...

Read More...